Delivery Order SPE2DB22D2211-SPE2DB25FSDRM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,997.78 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Butalbital-Acetaminophen-Caffeine-Codeine 50-300mg tablets (100 count). This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, represents a competitive award with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $1,040.73 to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets (100-count) on May 12, 2025, with an ultimate completion date of May 13, 2025. This firm fixed-price, non-competitive delivery order represents a single pharmaceutical supply transaction under AmerisourceBergen's broader federal contract portfolio. The product will be delivered to the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,012.85 to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine-Codeine 50-300mg tablets (100 count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,043.53 firm fixed price delivery order to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets (100 count) on July 28, 2025, with completion scheduled for July 29, 2025. This competitive award, issued without set-aside designation, is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets in quantities of 100 units. This is a competitively awarded, firm fixed price contract with no set-aside designation, valued at $1,474.20 and scheduled for completion by August 29, 2025. The product will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,714.19 to AmerisourceBergen Drug Corp for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (500 count) with a firm fixed price and completion date of August 27, 2025. This non-set-aside competitive award was made to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions provider. The...
- The Defense Logistics Agency awarded a $1,258.58 delivery order to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (500 count) on July 31, 2025, with completion expected by August 1, 2025. This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $4,242.27 delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (100 count). This firm fixed price delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets in quantities of 100 units, with a contract ceiling value of $1,228.50. This delivery order represents a firm fixed-price transaction with no set-aside designation, indicating competitive award. The contract is classified as a child action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,445.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Butalbital-Aspirin-Caffeine tablets (90-count). This non-set-aside contract was awarded competitively and has an ultimate completion date of September 16, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract issued...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDRMDelivery Order
The Defense Logistics Agency awarded a $4,394.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically Butalbital-Acetaminophen-Caffeine-Codeine 50-300mg in 100-count units. This non-set-aside contract was awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement under the federal medical supply chain managed by DLA. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp's continued selection for such contracts reflects its established capability to meet federal medical procurement requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 8/26/25 |